683 Capital Management, LLC Iovance Biotherapeutics, Inc. Transaction History

683 Capital Management, LLC

$1.24 Billion
Q1 2025

A detailed history of 683 Capital Management, LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, 683 Capital Management, LLC holds 2,400,000 shares of IOVA stock, worth $4.27 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares

2,400,000

Previous 1,416,014 69.49%

Holding current value

$4.27 Million

Previous $10.5 Million 23.73%

% of portfolio

0.64%

Previous 0.75%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$3.33 - $7.79 $3.28 Million - $7.67 Million	983,986 Added 69.49%	2,400,000 $7.99 Million
Q4 2024 Feb 14, 2025	BUY	$7.17 - $12.28 $114,820 - $196,651	16,014 Added 1.14%	1,416,014 $10.5 Million
Q3 2024 Nov 14, 2024	SELL	$7.28 - $11.9 $728,000 - $1.19 Million	-100,000 Reduced 6.67%	1,400,000 $13.1 Million
Q2 2024 Aug 14, 2024	BUY	$7.78 - $14.19 $2.14 Million - $3.9 Million	275,000 Added 22.45%	1,500,000 $12 Million
Q1 2024 May 15, 2024	SELL	$7.59 - $17.47 $3.98 Million - $9.17 Million	-525,000 Reduced 30.0%	1,225,000 $18.2 Million
Q4 2023 Feb 14, 2024	SELL	$3.3 - $8.89 $990,000 - $2.67 Million	-300,000 Reduced 14.63%	1,750,000 $14.2 Million
Q3 2023 Nov 14, 2023	BUY	$4.44 - $8.79 $2.89 Million - $5.71 Million	650,000 Added 46.43%	2,050,000 $9.33 Million
Q2 2023 Aug 14, 2023	BUY	$5.36 - $9.06 $402,000 - $679,500	75,000 Added 5.66%	1,400,000 $9.86 Million
Q1 2023 May 15, 2023	BUY	$5.53 - $8.22 $1.8 Million - $2.67 Million	325,000 Added 32.5%	1,325,000 $8.1 Million
Q4 2022 Feb 14, 2023	SELL	$5.62 - $10.0 $3.96 Million - $7.05 Million	-705,000 Reduced 41.35%	1,000,000 $6.39 Million
Q3 2022 Nov 14, 2022	SELL	$9.53 - $13.11 $2.81 Million - $3.87 Million	-295,000 Reduced 14.75%	1,705,000 $16.3 Million
Q2 2022 Aug 15, 2022	BUY	$6.38 - $18.33 $3.19 Million - $9.17 Million	500,000 Added 33.33%	2,000,000 $22.1 Million
Q1 2022 May 16, 2022	BUY	$12.38 - $19.1 $9.66 Million - $14.9 Million	780,000 Added 108.33%	1,500,000 $25 Million
Q4 2021 Feb 14, 2022	SELL	$16.55 - $27.63 $3.8 Million - $6.35 Million	-229,829 Reduced 24.2%	720,000 $13.7 Million
Q3 2021 Nov 15, 2021	SELL	$20.35 - $26.63 $1.53 Million - $2 Million	-75,000 Reduced 7.32%	949,829 $23.4 Million
Q2 2021 Aug 16, 2021	BUY	$16.33 - $33.07 $16.7 Million - $33.9 Million	1,024,829 New	1,024,829 $26.7 Million
Q1 2021 May 17, 2021	SELL	$28.67 - $52.59 $2.87 Million - $5.26 Million	-100,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$19.54 - $38.85 $1.95 Million - $3.89 Million	100,000 New	100,000 $2.99 Million
Q3 2018 Nov 14, 2018	SELL	$11.25 - $17.7 $3.94 Million - $6.2 Million	-350,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$8.1 - $19.5 $405,000 - $975,000	50,000 Added 16.67%	350,000 $5.92 Million
Q3 2017 Nov 14, 2017	BUY	$4.45 - $8.55 $1.34 Million - $2.57 Million	300,000	300,000 $2.33 Million

Others Institutions Holding IOVA

# of Institutions

337

Shares Held

247M

Call Options Held

1.34M

Put Options Held

1.61M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $281M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of 683 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 683 Capital Management, LLC with notifications on news.

Account

683 Capital Management, LLC Iovance Biotherapeutics, Inc. Transaction History